![Josiah Craver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josiah Craver
Comptroller/Controller/Auditor bij
FAETH THERAPEUTICS, INC.
Vermogen: - $ op 31-07-2026
Profiel
Josiah Craver is Chief Accounting Officer & Senior VP-Finance at Faeth Therapeutics, Inc. starting in 2026.
Former positions include Senior Vice President & Controller at Kala Bio, Inc., and Vice President-Finance at Solid Biosciences, Inc. from 2020.
Education includes undergraduate and graduate degrees from Stonehill College, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-07-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van Josiah Craver
| Bedrijven | Functie | Begin |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 17-09-2024 |
Eerdere bekende functies van Josiah Craver
| Bedrijven | Functie | Einde |
|---|---|---|
| SOLID BIOSCIENCES INC. | Comptroller/Controller/Auditor | 01-03-2020 |
| KALA BIO, INC. | Comptroller/Controller/Auditor | - |
Opleiding van Josiah Craver
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Stonehill College, Inc.
 Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
